Effect of Phalasarpis in reducing blood loss in cyclic heavy menstrual bleeding (Menorrhagia)

Effect of Phalasarpis on PBLAC score in Menorrhagia

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071308

Enrollment

Registered

2024-07-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Females of age group 16-50 years 2 Subjects with menorrhagia irrespective of its etiology 3 Subjects with regular menstrual bleeding for more than 7 days and/or excessive in amount for the last two consecutive menstrual cycles

Exclusion criteria

Exclusion criteria: 1 Bleeding associated with pregnancy or miscarriage 2 Subjects undergoing hormonal replacement therapy 3 Subjects with coagulation disorders 4 Subjects undergoing medication for any systemic illnesses 5 Hb level = 7 gm% 6 Subjects with mandagni assessed using agnibala assessment tool

Design outcomes

Primary

Measure	Time frame
To assess the reduction in amount of bleeding in menorrhagia using PBLAC ScoreTimepoint: PBLAC score on the 4th, 6th and 8th days of menstruation.	—

Secondary

Measure	Time frame
Reduction in bleeddingTimepoint: 8th day of menstruation	—

Countries

India

Contacts

Public ContactVinila Vinod A

P.N.N.M Ayurveda Medical College and Hospital

sitharasatheesan@gmail.com9496115109

Outcome results